GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Beneish M-Score

OrbusNeich Medical Group Holdings (FRA:Q8T) Beneish M-Score : -1.64 (As of Apr. 05, 2025)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.64 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's Beneish M-Score or its related term are showing as below:

FRA:Q8T' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: -2.09   Max: -1.64
Current: -1.64

During the past 6 years, the highest Beneish M-Score of OrbusNeich Medical Group Holdings was -1.64. The lowest was -2.90. And the median was -2.09.


OrbusNeich Medical Group Holdings Beneish M-Score Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Beneish M-Score Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial - -2.90 -2.09 -1.64 -

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.09 - -1.64 - -

Competitive Comparison of OrbusNeich Medical Group Holdings's Beneish M-Score

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Beneish M-Score falls into.


;
;

OrbusNeich Medical Group Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of OrbusNeich Medical Group Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2965+0.528 * 0.9763+0.404 * 1.5932+0.892 * 1.0924+0.115 * 1.2183
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8846+4.679 * 0.053741-0.327 * 1.2099
=-1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €46.1 Mil.
Revenue was €141.1 Mil.
Gross Profit was €97.7 Mil.
Total Current Assets was €319.1 Mil.
Total Assets was €376.1 Mil.
Property, Plant and Equipment(Net PPE) was €16.9 Mil.
Depreciation, Depletion and Amortization(DDA) was €3.9 Mil.
Selling, General, & Admin. Expense(SGA) was €50.3 Mil.
Total Current Liabilities was €32.7 Mil.
Long-Term Debt & Capital Lease Obligation was €1.2 Mil.
Net Income was €41.3 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €21.1 Mil.
Total Receivables was €32.6 Mil.
Revenue was €129.2 Mil.
Gross Profit was €87.3 Mil.
Total Current Assets was €296.7 Mil.
Total Assets was €331.4 Mil.
Property, Plant and Equipment(Net PPE) was €12.6 Mil.
Depreciation, Depletion and Amortization(DDA) was €3.7 Mil.
Selling, General, & Admin. Expense(SGA) was €52.0 Mil.
Total Current Liabilities was €22.5 Mil.
Long-Term Debt & Capital Lease Obligation was €2.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(46.135 / 141.094) / (32.575 / 129.162)
=0.326981 / 0.252203
=1.2965

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(87.28 / 129.162) / (97.659 / 141.094)
=0.675741 / 0.692156
=0.9763

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (319.082 + 16.933) / 376.102) / (1 - (296.676 + 12.554) / 331.401)
=0.106585 / 0.066901
=1.5932

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=141.094 / 129.162
=1.0924

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.665 / (3.665 + 12.554)) / (3.856 / (3.856 + 16.933))
=0.22597 / 0.185483
=1.2183

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(50.288 / 141.094) / (52.041 / 129.162)
=0.356415 / 0.402913
=0.8846

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.243 + 32.667) / 376.102) / ((2.217 + 22.479) / 331.401)
=0.090162 / 0.07452
=1.2099

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(41.332 - 0 - 21.12) / 376.102
=0.053741

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

OrbusNeich Medical Group Holdings has a M-score of -1.67 signals that the company is likely to be a manipulator.


OrbusNeich Medical Group Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines